Abstract
The correlations of nm23-H1 expression in primary cancer lesions with the already confirmed 14 prognostic variables and survival were examined in 52 advanced colorectal cancer patients, because the clinical roles of nm23-H1 expression in the cancer lesions remain controversial. An immunohistochemical expression of nm23-H1 was found in 23 lesions (positive group) but not found in 29 lesions (negative group). No significant difference between the positive and negative groups was found according to 12 clinicopathological variables including vascular invasion, lymph node and liver metastases, and histological stage. The carcinoembryonic antigen levels (21.5±33.4 ng/ml) of the draining venous blood and argyrophilic nucleolar organizer regions score (3.35±1.36 per nucleus) of the cancer cells in the positive group were not significantly different from those (34.1±102.9 ng/ml and 3.32±1.00 per nucleus, respectively) in the negative group. In addition, no significant difference was found in the survival curves or the 5-year survival rates of the positive and negative groups. From these results, it may be concluded that the nm23-H1 expression was not associated with the aforementioned prognostic variables and the prognosis of advanced colorectal cancer patients.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA, Sobel ME (1988) Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 80:200–204
Bevilacqua G, Sobel ME, Liotta LA, Steeg PS (1989) Association of low nm23 RNA levels in human primary infiltrating ductal carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res 49:5185–5190
Hirayama R, Sawai S, Takagi Y, Mishima Y, Kimura N, Shimada N, Takahashi T (1991) Positive relationship between expression of anti-metastatic factor (nm23 gene product or nucleoside diphosphate kinase) and good prognosis in human breast cancer. J Natl Cancer Inst 83:1249–1250
Hennessy C, Henry JA, May FEB, Westley BR, Angus B, Lennard TW (1991) Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. J Natl Cancer Inst 83:281–285
Barnes R, Masood S, Barker E, Rosengard AM, Coggin DL, Crowell T, King CR, Porter-Jordan K, Wargotz ES, Liotta LA, Steeg PS (1991) Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival. Am J Pathol 139:245–250
Nakayama H, Yasui W, Yokozaki H, Tahara E (1993) Reduced expression of nm23 is associated with metastasis of human gastric carcinomas. Jpn J Cancer Res 84:184–190
Ayhan A, Yasui W, Yokozaki H, Kitadai Y, Tahara E (1993) Reduced expression of nm23 protein is associated with advanced tumor stage and distant metastases in human colorectal carcinomas. Virchows Arch B Cell Pathol 63:213–218
Yamaguchi A, Urano T, Fushida S, Furukawa K, Nishimura G, Yonemura Y, Miyazaki I, Nakagawara G, Shiku H (1993) Inverse association of nm23-H1 expression by colorectal cancer with liver metastasis. Br J Cancer 68:1020–1024
Kodera Y, Isobe K, Yamauchi M, Kondoh K, Kimura N, Akiyama S, Itoh K, Nakashima I (1994) Expression of nm23-H1 RNA levels in human gastric cancer tissues. Cancer 73:259–265
Royds JA, Cross SS, Silcocks PB, Scholefield JH, Rees RC, Stephenson TJ (1994) Nm23 “anti-metastatic” gene product expression in colorectal carcinoma. J Pathol 172:261–266
Florenes VA, Aamdal S, Myklebost O, Maelandsmo GM, Bruland OS, Fodstad O (1992) Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression. Cancer Res 52:6088–6091
Hailat N, Keim DR, Melhem RF, Zhu XX, Eckerskorn C, Brodeur GM, Reynolds CP, Seeger RC, Lottspeich F, Strahler JR, Hanash SM (1991) High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J Clin Invest 88:341–345
Sastre-Garau X, Lacombe ML, Jouve M, Veron M, Madgelenat H (1992) Nucleoside diphosphate kinase/nm23 expression in breast cancer: lack of correlation with lymph-node metastasis. Int J Cancer 50:533–538
Zeng ZS, Hsu S, Zhang ZF, Cohen AM, Enker WE, Turnbull AA, Guillem JG (1994) High level of nm23-H1 gene expression is associated with local colorectal cancer progression not with metastases. Br J Cancer 70:1025–1030
Russell RL, Geiginger KR, Mehta RR, White WL, Shelton B, Kute TE (1997) Nm23-relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients. Cancer 79:1158–1165
Dickson RB, Lippman ME (1997) Cancer of the breast. In De Vita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology (5th edn). Lippincott-Raven, Philadelphia, pp 1514–1616
Japanese Research Society for Cancer of the Colon and Rectum (1997) Japanese classification of colorectal carcinoma (First English edn). Kanehara, Tokyo
Crocker J, Nar P (1987) Nucleolar organizer regions in lymphomas. J Pathol 151:111–118
Smith R, Crocker J (1988) Evaluation of nucleolar organizer regions-associated proteins in breast malignancy. Histopathology 12:113–124
Young AN, Wang TY, Liu HC (1992) Comparative study of prognostic value or nucleolar grade and silver-binding nucleolar organizer region in renal cell carcinomas. J Pathol 166:157–161
Tabuchi Y, Nakamura T, Nakae S (1996) Argyrophilic nucleolar organizer regions (AgNOR) in colorectal cancer patients: correlation with survival. Bull Allied Med Sci (Kobe) 12:83–87
Tabuchi Y, Deguchi H, Imanishi K, Saitoh Y (1991) Colorectal cancer patients with high risk of hematogenous metastases: correlation with CEA levels in peripheral and draining venous blood during the period of operation. J Surg Oncol 47:87–91
Tabuchi Y, Deguchi H, Imanishi K, Saitoh Y (1992) Carcinoembryonic antigen levels of peripheral and draining venous blood in patients with colorctal cancer: correlation with survival. Cancer 69:2411–2417
Tabuchi Y, Nakamura T, Kuniyasu T (1998) A predictive value of carcinoembryonic antigen in draining venous blood for colorectal cancer patients with postoperative hematogenous metastases. Cancer Detect Prevent 22:57–61
Nakamura T, Tabuchi Y, Ohno M (1997) Clinicopathological role of nm23 expression in early gastric cancer. Bull Allied Med Sci (Kobe) 13:177–182
Rosengard AM, Krutzsch HC, Shearn A, Biggs JR, Baker E, Margulies IK, King CR, Liotta LA, Steeg PS (1989) Reduced nm23/Awd protein in tumor metastasis and aberrant drosophila development. Nature 342:177–180
Stahl JA, Leone A, Rosengard AM, Proter L, King CR, Steeg PS (1991) Identification of a second nm23 gene, nm23-H2. Cancer Res 51:445–449
Gills AM, Presecan E, Vonica A (1991) Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexametric enzyme. J Biol Chem 266:8784–8789
Leone A, Flatow U, VanHoutte K, Steeb PS (1993) Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. Oncogene 8:2325–2333
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tabuchi, Y., Nakamura, T., Kuniyasu, T. et al. Expression of nm23-H1 in colorectal cancer: No association with metastases, histological stage, or survival. Surg Today 29, 116–120 (1999). https://doi.org/10.1007/BF02482235
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02482235